Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

  • receive the eCopy two days prior to the printed edition.
  • can partake in our online MCQs.
  • can enter our online sports quiz. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

You are reading 1 of 2 free-access articles allowed for 30 days

Mater agrees to take back patients screened in St James’s

By Mindo - 02nd Nov 2018 | 17 views

At a meeting of the NCCP Executive in March, the minutes of which were seen by the <strong>Medical Independent</strong> (<strong>MI</strong>) through Freedom of Information legislation, the transfer of patients from the Mater to the specialist cancer genetics service in St James’s was discussed.

“Mater has not yet confirmed if they will take back patients after having been seen in James’s,” according to the minutes. “This is holding up transfer of patient list to James’s. [The] matter is critical and needs to resolved immediately.”

The NCCP hereditary cancer programme oversees the development of specialist cancer genetics services, which relate to an individual’s inherited predisposition to developing cancer. 

The specialist cancer genetics services are provided by St James’s and the Clinical Genetics Department at Our Lady’s Children’s Hospital, Crumlin.

The issue was in relation to patients who had been referred to a service in the Mater that was no longer in operation. It was arranged that these patients would be transferred to the cancer genetics service at St James’s.

Patients are referred to a specialist cancer genetics service for an assessment of their likely risk, followed by counselling and genetic testing, if indicated. Management recommendations are made based on the results of the risk assessment and genetic test results. 

Subsequently, patients are referred back to the original hospital for follow-up, which may involve clinics, surveillance imaging, drug treatment and/or risk-reducing surgery.

 An NCCP spokesperson told this newspaper that the issue has now been resolved.

“Clarity was requested from the Mater that they would continue to provide the required follow-up for these patients and this assurance was given,” said the spokesperson.

Leave a Reply

Latest Issue
medical news
The Medical Independent 19th May 2022

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read